Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
AssigneeAegera Therapeutics, Inc.
InventorsRobert G. Korneluk, Alexander E. MacKenzie, Stephen Baird, Peter Liston
Life of this patent
Estimating the term…
Abstract
Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; substantially pure polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primers and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
Claims6
A substantially pure polypeptide, wherein said polypeptide has at least 95% amino acid sequence identity to any one of SEQ ID NOS:
- 4, 6, 8, 10, or 40, and comprises a domain having a sequence selected from the group consisting of amino acids 26-93, 163-230, or 265-330 of SEQ ID NO:
- 4, amino acids 29-96, 169-235, or 255-322 of SEQ ID NO:
- 6, amino acids 46-113, 184-250, or 269-336 of SEQ ID NO:
- 8, amino acids 26-93, 163-230, or 264-329 of SEQ ID NO:
- 10, or amino acids 29-96, 169-235, or 255-322 of SEQ ID NO:
- 40, wherein said polypeptide inhibits apoptosis.
The polypeptide of claim wherein 3, said polypeptide is M-XIAP (SEQ ID NO:
- 10).
Dependencies are inferred from the claim text.